Both Tebio (i.e. recombinant human thrombopoietin injection) and interleukin (recombinant human interleukin-11 injection) have better platelet-raising effects. Recombinant human interleukin-11 for injection, its mechanism is through the stimulation of hematopoietic stem cells and megakaryocyte proliferation, inducing megakaryocyte maturation and differentiation, thereby elevating platelets; allergy to this drug is prohibited. Adverse reactions include fatigue, pain, fever, nausea. Recombinant human thrombopoietin injection, which has a stimulating effect on all stages of megakaryocyte generation to elevate platelets. It is contraindicated in patients with allergy, severe cardiovascular and cerebrovascular diseases, severe infections and recent thrombosis. Adverse reactions include fever, muscle aches, dizziness, and elevated blood pressure. Recombinant human thrombopoietin injection and injection recombinant human interleukin-11 both have the effect of elevating platelets, but the price of recombinant human thrombopoietin is relatively expensive a little bit, exclusion of the contraindications of the two drugs, according to the patient’s condition, follow the doctor’s instructions.